ask="4.35"
ask_size="400"
average_daily_volume="501740"
bid="3.30"
bid_size="100"
book_value="2.30"
change="-0.08"
change_from_200_day_moving_average="-0.78"
change_from_50_day_moving_average="-0.32"
change_from_52_week_high="-2.82"
change_From_52_week_low="0.88"
change_in_percent="-1.97%"
close="3.98"
dividend_pay_date="12/30/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.68"
ebitda="-43.09M"
eps_estimate_current_year="-1.47"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.84"
ex_dividend_date="12/31/2013"
float_shares="39812000"
high="4.13"
high_52_weeks="6.80"
last_trade_date="3/2/2017"
last_trade_price="3.98"
last_trade_size="1038"
last_trade_time="4:00pm"
low="3.95"
low_52_weeks="3.10"
market_capitalization="260.40M"
moving_average_200_day="4.76"
moving_average_50_day="4.30"
name="Aralez Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="8.75"
open="4.02"
pe_ratio="N/A"
peg_ratio="-0.09"
percent_change_from_200_day_moving_average="-16.39%"
percent_change_from_50_day_moving_average="-7.35%"
percent_change_from_52_week_high="-41.47%"
percent_change_from_52_week_low="+28.39%"
previous_close="4.06"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.76"
price_per_sales="6.60"
revenue="40.23M"
shares_outstanding="65427000"
short_ratio="8.92"
stock_exchange="NMS"
symbol="ARLZ"
volume="373567"
weeks_range_52="3.10 - 6.80"
